Transcription factor EB regulates cardiovascular homeostasis

Area of Science:

• Molecular biology
• Cardiovascular research
• Cellular homeostasis

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of death and disability.
• Transcription factor EB (TFEB) is a key regulator of autophagy and lysosomal biogenesis.
• Emerging evidence highlights TFEB's role in cardiovascular homeostasis and its protective effects.

Purpose of the Study:

• To explore the role of Transcription factor EB (TFEB) in cardiovascular health.
• To investigate TFEB's potential as a therapeutic target for cardiovascular diseases (CVDs).
• To understand the mechanisms underlying TFEB's beneficial effects on the cardiovascular system.

Main Methods:

• Review of emerging studies on TFEB function in cardiovascular contexts.
• Analysis of TFEB's role in regulating autophagy and lysosomal biogenesis.
• Examination of TFEB's impact on various cardiovascular conditions like atherosclerosis and cardiotoxicity.

Main Results:

• TFEB demonstrates beneficial effects in models of atherosclerosis, aortic aneurysm, and cardiotoxicity.
• Post-translational modifications critically influence TFEB's activity and localization.
• Therapeutic strategies aimed at enhancing TFEB activity are being developed.

Conclusions:

• Transcription factor EB (TFEB) is a promising molecular target for preventing and treating cardiovascular diseases (CVDs).
• Further elucidation of TFEB's mechanisms will facilitate the development of novel TFEB-based therapies.
• Targeting TFEB offers a potential avenue for improving cardiovascular health and managing heart conditions.